Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Perales

MSKCC Early Experience Using Radiotherapy as a Bridging Strategy for Relapsed Diffuse Large B Cell Lymphoma Before Cd19 Car T Therapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Allogeneic Hematopoietic Cell Transplantation Impacts on Immune Evasive Mechanisms in Relapsed/Refractory Diffuse Large B-Cell Lymphoma - A Single Center Experience

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Related publications

Cd19-Directed Car T Cell Therapy (Ctl019) for Relapsed/Refractory Diffuse Large B-Cell and Follicular Lymphomas: Four Year Outcomes

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Establishing a Model System for Evaluating CAR T Cell Therapy Using Dogs With Spontaneous Diffuse Large B Cell Lymphoma

OncoImmunology
OncologyAllergyImmunology
2019English

Novel BAFF-R CAR T-Cell Therapy for CD19 Antigen-Loss Relapsed B Cell Tumors

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Is Radiotherapy Still Necessary for Diffuse Large B-Cell Lymphoma Therapy?

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2015English

Non-Myeloablative Allogeneic Haematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: A Multicentre Experience

British Journal of Haematology
Hematology
2008English

Molecular Analysis of a CD19-negative Diffuse Large B-Cell Lymphoma

Haematologica
Hematology
2018English

Rapid Relapse of Large B‐Cell Lymphoma After CD19 Directed CAR‐T‐Cell Therapy Due to CD‐19 Antigen Loss

American Journal of Hematology
Hematology
2019English

MDS as a Cause for Prolonged Hematologic Toxicity After Treatment With Cd19 Targeted Car-T Cell Therapy in Patients With Relapsed Refractory Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Cd19/Cd20-Redirected Bispecific Car T Cell Treatment in Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy